SCHEMBL3883201

SCHEMBL3883201

O=C(O)CCc1ccc(OCCC2CCCCC2)c(-c2ccc3ccccc3c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 6/20 0.53
C5AR1 P21730 1/20 0.45
PPARG P37231 3/20 0.43
THRA P10827 1/20 0.42
THRB P10828 1/20 0.42
FFAR1 O14842 1/20 0.42
PPARD Q03181 1/20 0.42
CCNC P24863 1/20 0.41
CDK8 P49336 1/20 0.41
CYSLTR2 Q9NS75 1/20 0.41
CYSLTR1 Q9Y271 1/20 0.41
CYP1A2 P05177 1/20 0.41
PTGES O14684 1/20 0.41
ALOX5 P09917 1/20 0.41
IDO1 P14902 1/20 0.40
ITGB3 P05106 1/20 0.40
ITGA2B P08514 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
CASR P41180 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3881750 0.99 FFAR4 (0.53) FFAR4C5AR1PPARGTHRATHRB
SCHEMBL3888439 0.90 FFAR4 (0.54) FFAR4C5AR1THRATHRBFFAR1
SCHEMBL3894265 0.90 C5AR1 (0.47) FFAR4C5AR1PPARGFFAR1PPARD
SCHEMBL3883274 0.89 FFAR4 (0.55) FFAR4C5AR1THRATHRBFFAR1
SCHEMBL3881246 0.89 CCNC (0.46) FFAR4C5AR1PPARGFFAR1PPARD
SCHEMBL3886327 0.84 PPARG (0.50) C5AR1PPARGFFAR1PPARDPTGES
SCHEMBL3883711 0.84 FFAR4 (0.57) FFAR4THRATHRBFFAR1CCNC
SCHEMBL3887901 0.83 FFAR4 (0.58) FFAR4FFAR1CCNCCDK8CYP1A2
SCHEMBL3677382 0.83 CYP1A2 (0.53) FFAR4C5AR1THRATHRBPPARD
SCHEMBL3884628 0.83 PPARG (0.48) C5AR1PPARGFFAR1PPARDPTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 FFAR4 115/4885C5AR1 282/4885PPARG 59/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.